BCAT1 and neoplasm: Mechanistically, high expression of BCAT1 reduces the NAD+/NADH ratio, increases mTORC1 activity, and promotes oxidative phosphorylation and nucleotide biosynthesis.64 The results of Zhang et al. illustrate the feasibility of targeting BCAAs metabolism in GBM for tumor therapy (Fig. 4).